OTC Link
SYROS PHARMACEUTICALS INC
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2024-10-31 | Q3 2024 | -0.72 | -0.16 | +77.78% | $0 | ✅ Beat | -10.12% | +1.59% | -89.80% |
| 2024-07-31 | Q2 2024 | -0.77 | -0.59 | +23.38% | $0 | ✅ Beat | -5.50% | -16.50% | -72.67% |
| 2024-05-14 |
| Q1 2024 |
| -0.87 |
| -0.10 |
| +88.51% |
| $0 |
| ✅ Beat |
| +1.47% |
| +4.05% |
| +6.81% |
| 2024-03-27 | Q4 2023 | -1.14 | -2.18 | -91.23% | $387,000 | ❌ Miss | — | — | — |
| 2023-11-14 | Q3 2023 | -1.14 | -1.43 | -25.44% | $3.8M | ❌ Miss | +11.76% | +6.62% | +59.19% |
| 2023-08-08 | Q2 2023 | -1.13 | -1.30 | — | $2.8M | ➖ Inline | +1.91% | +4.10% | +5.74% |
| 2023-03-02 | Q4 2022 | -1.35 | -0.17 | +87.41% | $-754,000 | ✅ Beat | +4.52% | -3.99% | -31.91% |
Showing last 7 quarters.